Clinical Trials Using Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318

Clinical trials are research studies that involve people. The clinical trials on this list are studying Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • A Phase I Study of PLX038 in Patients With Advanced Solid Tumors

    This is a Phase I, open-label, two-arm, dose escalation study of PLX038 intravenous infusion administered to patients with refractory or relapsed solid tumors. This study will explore two different dosing schedules: Arm 1, once every 3 week (q3w), and Arm 2, once weekly for 2 consecutive weeks of a 4-week cycle.
    Location: M D Anderson Cancer Center, Houston, Texas